Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review

Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Johnson & Johnson (J&J) researches, develops, manufactures, and sells pharmaceutical products and medical devices. The company conducts business through its operating companies. It provides pharmaceuticals for immune disorders, cancer, neurological disorders, infectious, cardiovascular, and metabolic diseases; and medical devices for use in cardiovascular, orthopaedic, neurovascular care, general surgery and vision care fields. J&J distributes pharmaceutical and medical products to retailers, wholesalers, healthcare professionals and hospitals. The company offers its products in the US; Europe; Asia-Pacific and Africa; and Western Hemisphere (excluding the US) and Latin America. J&J is headquartered in New Brunswick, New Jersey, the US.

Johnson & Johnson Key Recent Developments

Apr 22,2024: Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
Apr 18,2024: Essential Pharma acquires Reminyl from Janssen Pharmaceutica
Apr 16,2024: Johnson & Johnson Reports Q1 2024 Results
Apr 15,2024: Digital Therapeutics Startup Respiree Announces Incorporation in US with Residency at Jlabs San Francisco

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Johnson & Johnson - Key Facts
Johnson & Johnson - Key Employees
Johnson & Johnson - Key Employee Biographies
Johnson & Johnson - Major Products and Services
Johnson & Johnson - History
Johnson & Johnson - Company Statement
Johnson & Johnson - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Johnson & Johnson - Business Description
Business Segment: Innovative Medicine
Overview
Performance
Key Stats
Business Segment: MedTech
Overview
Performance
Key Stats
Geographical Segment: Asia-Pacific, Africa
Performance
Geographical Segment: Europe
Performance
Geographical Segment: United States
Performance
Geographical Segment: Western Hemisphere excluding U.S.
Performance
R&D Overview
Johnson & Johnson - Corporate Strategy
Johnson & Johnson - SWOT Analysis
SWOT Analysis - Overview
Johnson & Johnson - Strengths
Johnson & Johnson - Weaknesses
Johnson & Johnson - Opportunities
Johnson & Johnson - Threats
Johnson & Johnson - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Johnson & Johnson, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 22, 2024: Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
Apr 18, 2024: Essential Pharma acquires Reminyl from Janssen Pharmaceutica
Apr 16, 2024: Johnson & Johnson Reports Q1 2024 Results
Apr 15, 2024: Digital Therapeutics Startup Respiree Announces Incorporation in US with Residency at Jlabs San Francisco
Apr 02, 2024: Johnson & Johnson to Participate in the BofA Securities Health Care Conference
Mar 28, 2024: Johnson & Johnson Innovation Commemorates Agreement with Korean Ministry of Health and Welfare on Operation of the Global Accelerator Platform for Early-Stage Biotech and Medtech Companies
Mar 19, 2024: Innovation in Healthcare and Digital Technologies Boosts European Patent Applications by U.S. Companies
Mar 18, 2024: Johnson & Johnson MedTech working with NVIDIA to scale AI for surgery
Mar 18, 2024: Tikva Allocell Joins the Johnson & Johnson Innovation – JLABS community
Mar 12, 2024: Johnson & Johnson Innovation Names Finalists in Atopic Advancements QuickPitch
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Johnson & Johnson, Key Facts
Johnson & Johnson, Key Employees
Johnson & Johnson, Key Employee Biographies
Johnson & Johnson, Major Products and Services
Johnson & Johnson, History
Johnson & Johnson, Subsidiaries
Johnson & Johnson, Key Competitors
Johnson & Johnson, Ratios based on current share price
Johnson & Johnson, Annual Ratios
Johnson & Johnson, Annual Ratios (Cont...1)
Johnson & Johnson, Annual Ratios (Cont...2)
Johnson & Johnson, Interim Ratios
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Johnson & Johnson, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Johnson & Johnson, Performance Chart (2019 - 2023)
Johnson & Johnson, Ratio Charts
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals by Type, 201

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings